SRPT logo

Sarepta Therapeutics (SRPT) Long Term Liabilities

Annual Total Long Term Liabilities

$1.75 B
-$372.23 M-17.53%

December 31, 2023


Summary


Performance

SRPT Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSRPTbalance sheetmetrics:

Quarterly Long Term Liabilities

$1.68 B
+$20.68 M+1.25%

September 30, 2024


Summary


Performance

SRPT Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSRPTbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

SRPT Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.5%0.0%
3 y3 years-3.1%-20.9%
5 y5 years+301.6%-20.9%

SRPT Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-17.5%at low-20.9%+1.5%
5 y5-year-17.5%+136.7%-20.9%+127.0%
alltimeall time-17.5%>+9999.0%-20.9%>+9999.0%

Sarepta Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$1.68 B(+1.2%)
Jun 2024
-
$1.66 B(+0.3%)
Mar 2024
-
$1.65 B(-5.5%)
Dec 2023
$1.75 B(-17.5%)
$1.75 B(-7.5%)
Sep 2023
-
$1.89 B(+0.5%)
Jun 2023
-
$1.89 B(+4.2%)
Mar 2023
-
$1.81 B(-14.8%)
Dec 2022
$2.12 B(+20.2%)
$2.12 B(+0.1%)
Sep 2022
-
$2.12 B(+23.0%)
Jun 2022
-
$1.72 B(-1.1%)
Mar 2022
-
$1.74 B(-1.3%)
Dec 2021
$1.77 B(-2.2%)
$1.77 B(-2.9%)
Sep 2021
-
$1.82 B(-1.6%)
Jun 2021
-
$1.85 B(-0.9%)
Mar 2021
-
$1.87 B(+3.2%)
Dec 2020
$1.81 B(+144.2%)
$1.81 B(+19.6%)
Sep 2020
-
$1.51 B(+1.7%)
Jun 2020
-
$1.49 B(-0.7%)
Mar 2020
-
$1.50 B(+102.2%)
Dec 2019
$739.87 M(+69.7%)
$739.87 M(+50.6%)
Sep 2019
-
$491.41 M(+1.0%)
Jun 2019
-
$486.50 M(+1.8%)
Mar 2019
-
$477.96 M(+9.6%)
Dec 2018
$436.11 M(+1.3%)
$436.11 M(+1.7%)
Sep 2018
-
$428.67 M(-3.3%)
Jun 2018
-
$443.43 M(+2.6%)
Mar 2018
-
$432.33 M(+0.4%)
Dec 2017
$430.42 M(+3489.5%)
$430.42 M(+1218.1%)
Sep 2017
-
$32.66 M(+409.7%)
Jun 2017
-
$6.41 M(-17.5%)
Mar 2017
-
$7.76 M(-35.3%)
Dec 2016
$11.99 M(-43.3%)
$11.99 M(-12.8%)
Sep 2016
-
$13.75 M(-12.3%)
Jun 2016
-
$15.68 M(-18.5%)
Mar 2016
-
$19.24 M(-9.0%)
Dec 2015
$21.14 M
$21.14 M(-11.4%)
DateAnnualQuarterly
Sep 2015
-
$23.85 M(-12.9%)
Jun 2015
-
$27.37 M(+240.3%)
Mar 2015
-
$8.04 M(-23.5%)
Dec 2014
$10.51 M(+25.0%)
$10.51 M(+3.8%)
Sep 2014
-
$10.13 M(+26.9%)
Jun 2014
-
$7.98 M(-7.9%)
Mar 2014
-
$8.67 M(+3.1%)
Dec 2013
$8.41 M(+246.4%)
$8.41 M(+31.5%)
Sep 2013
-
$6.39 M(+168.8%)
Jun 2013
-
$2.38 M(-0.9%)
Mar 2013
-
$2.40 M(-1.2%)
Dec 2012
$2.43 M(-11.7%)
$2.43 M(-0.8%)
Sep 2012
-
$2.45 M(-0.9%)
Jun 2012
-
$2.47 M(-8.6%)
Mar 2012
-
$2.70 M(-1.7%)
Dec 2011
$2.75 M(-6.3%)
$2.75 M(-1.8%)
Sep 2011
-
$2.80 M(-1.6%)
Jun 2011
-
$2.85 M(-1.6%)
Mar 2011
-
$2.89 M(-1.5%)
Dec 2010
$2.94 M(+1.6%)
$2.94 M(+0.1%)
Sep 2010
-
$2.93 M(-0.9%)
Jun 2010
-
$2.96 M(-1.8%)
Mar 2010
-
$3.01 M(+4.2%)
Dec 2009
$2.89 M(+14.9%)
$2.89 M(+12.9%)
Sep 2009
-
$2.56 M(+0.7%)
Jun 2009
-
$2.54 M(+1.2%)
Mar 2009
-
$2.51 M(-0.2%)
Dec 2008
$2.52 M(+0.5%)
$2.52 M(+0.2%)
Sep 2008
-
$2.51 M(+0.1%)
Jun 2008
-
$2.51 M(-1.7%)
Mar 2008
-
$2.55 M(+1.9%)
Dec 2007
$2.50 M
$2.50 M(+19.9%)
Sep 2007
-
$2.09 M(-0.8%)
Jun 2007
-
$2.11 M(-2206.7%)
Sep 1999
-
-$100.00 K(-103.2%)
Mar 1997
-
$3.10 M

FAQ

  • What is Sarepta Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual total long term liabilities year-on-year change?
  • What is Sarepta Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly long term liabilities year-on-year change?

What is Sarepta Therapeutics annual total long term liabilities?

The current annual total long term liabilities of SRPT is $1.75 B

What is the all time high annual total long term liabilities for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual total long term liabilities is $2.12 B

What is Sarepta Therapeutics annual total long term liabilities year-on-year change?

Over the past year, SRPT annual total long term liabilities has changed by -$372.23 M (-17.53%)

What is Sarepta Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of SRPT is $1.68 B

What is the all time high quarterly long term liabilities for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly total long term liabilities is $2.12 B

What is Sarepta Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, SRPT quarterly total long term liabilities has changed by $0.00 (0.00%)